UPDATE: Jefferies Raises PT on Cerner Corporation on Competitive Inroads
In a report published Friday, Jefferies analyst David Windley reiterated a Buy rating on Cerner Corporation (NASDAQ: CERN), and raised the price target from $97.00 to $110.00.
In the report, Windley noted, “In recent presentations, KLAS (HCIT independent rating org) described current competitive trends in the EHR space, and Premier (GPO) members forecasted continued high IT spending. Epic is still the dominant player, but CERN is making competitive inroads with decision makers; raising CERN PT to $110. ATHN has higher stickiness and promoter scores than industry averages. MDRX has fallen off clients' radars, and has a lot of work to do.”
Cerner Corporation closed on Thursday at $95.54.
Latest Ratings for CERN
|Feb 2017||Avondale Partners||Downgrades||Market Outperform||Market Perform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.